cancers-logo

Journal Browser

Journal Browser

Psychological Factors and Cancer Survivorship

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Survivorship and Quality of Life".

Deadline for manuscript submissions: 30 September 2026 | Viewed by 824

Editors


E-Mail Website
Guest Editor
Department of Clinical and Health Psychology, College of Public Health and Health Professions, University of Florida, Gainesville, FL 32610, USA
Interests: psycho-oncology; clinical health psychology

E-Mail Website
Guest Editor
Department of Neurosurgery, The University of Florida College of Medicine, Gainesville, FL, USA
Interests: brain tumor; neuro-oncology

Special Issue Information

Dear Colleagues,

The cancer survivorship spectrum starts when symptoms are detected and continues throughout diagnosis, treatment, and end-of-life. Individual psychosocial and quality of life (QOL) experiences in cancer are non-linear across the survivorship spectrum and are diverse in frequency, intensity, and persistence over time. These factors also vary across cancer type, survivorship phase, and the treatment type, responsiveness, toxicities, and outcomes.

Psychosocial, quality of life (QOL), and cultural factors are intersectional among individuals with cancer and have downstream effects on cancer biomarkers and outcomes. Negative psychosocial experiences, such as distress, are often clinically significant and impairing; however, notably, they often co-exist with positive experiences, such as meaning-making.

These biopsychosocial effects are responsive to psychological and behavioral interventions aimed at mitigating distress and enhancing overall wellness. Interventions vary in how they are delivered, length of treatment, therapeutic approach, and effectiveness.

This Special Issue will enhance the visibility of clinically significant, novel research addressing the aforementioned topics for both cancer researchers and clinicians. This issue will also enrich knowledge about biopsychosocial–cultural relationships and will optimize awareness about how interventions improve distress and clinical outcomes in cancer. Additional goals include filling gaps in the extant research and advancing the current state-of-the-science about how to improve mental and physical QOL and, ultimately, clinical outcomes.

I look forward to receiving your contributions.

Dr. Deidre B. Pereira
Dr. Ashley P. Ghiaseddin
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • psycho-oncology
  • distress
  • distress management
  • biobehavior markers and mechanisms
  • quality of life outcomes
  • treatment outcomes
  • survival outcomes

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

16 pages, 1180 KB  
Commentary
Emerging Perspectives on Adverse Childhood Experiences and Brain Cancer Immunotherapy
by John W. Figg, Julian Mark, Caretia J. Washington, Anna Fusco, Maegan A. Cremer, Scott A. Cohen, Stephan Quintin, Deidre B. Pereira and Ashley P. Ghiaseddin
Cancers 2026, 18(12), 1882; https://doi.org/10.3390/cancers18121882 - 9 Jun 2026
Viewed by 413
Abstract
Adverse childhood events (ACEs) represent a major public health burden in the United States, as exposure to ACEs increases the risk of mental health disorders, cardiovascular disease, obesity, and cancer and can greatly affect quality of life. Although the effects of ACEs on [...] Read more.
Adverse childhood events (ACEs) represent a major public health burden in the United States, as exposure to ACEs increases the risk of mental health disorders, cardiovascular disease, obesity, and cancer and can greatly affect quality of life. Although the effects of ACEs on physiology are complex, significant evidence suggests that ACEs may affect the immune system later in life. As the field of immunotherapy gains prominence in cancer treatment, it becomes imperative to explore how ACEs may impact cancer immunotherapy. Brain cancer, especially glioblastoma multiforme (GBM), has a very poor prognosis and remains a challenging disease to treat. Immunotherapy approaches are being actively investigated. To address this, we aim to raise awareness of the potential connection between ACEs, brain cancer, and cancer immunotherapy. Through a review of the current biomedical literature, we synthesized current findings into a commentary on how early-life adversity may influence the immune response within the central nervous system. It is the intention of this commentary to generate hypothesis-driven research within the nascent and emerging field of neuro-psycho-immunology in neuro-oncology. Given that the relationship between ACEs and brain cancer immunotherapy remains vastly understudied, this commentary has significant potential to generate insightful discussions among clinicians and scientists to guide further clinical and basic research towards anticipating which patients stand to receive the most benefit from immunotherapy. Full article
(This article belongs to the Special Issue Psychological Factors and Cancer Survivorship)
Show Figures

Figure 1

Back to TopTop